DOCSLIB.ORG

Special Drug Groups 2

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Special Drug Groups 2 Copyright Material – Provided by Taylor & Francis Special Drug Groups 2 Acetylcholinesterase Inhibitors While acetylcholinesterase inhibitors were historically used as pesticides and herbicides, in recent years they have been used to develop medica- tions to treat Alzheimer’s disease and myasthenia gravis. Commonly, their toxicity is measured by the percentage of acetylcholinesterase (ACh) activ- ity with toxicity beginning 20% below the level of normal activity (or 80% activity level) and becoming pronounced by 50% activity level. Severe tox- icity and death occur at 90% suppression (measured activity level = 10%). Postmortem testing should utilize the red blood cell (RBC), ACh as it better reflects neural ACh activity. Table 2.1 is a non-comprehensive list of common drugs, nerve agents, and insecticide/pesticides that are acetylcholinesterase inhibitors. 3 Copyright Material – Provided by Taylor & Francis 4 Table 2.1 Acetylcholinesterase Inhibitors Drugs—Alzheimer’s disease Drugs—myasthenia gravis Drugs—glaucoma Poisons—nerve agents Donepezil (Aricept) Ambenonium (Mytelase) Demecarium (Humorsol) Cyclosarin Galantamine (Razadyne, Reminyl, Edrophonium (Tensilon, Enlon, Echothiophate (Phospholine iodide) Sarin Nivalin) Reversol) Soman Medical for ExaminersHandbook Toxicology Forensic of Huperzine A Neostigmine (Prostigmin) Tabun Ladostigil Physostigmine (Antilirium) VX Metrifonate Pyridostigmine (Mestinon, VE Rivastigmine (Exelon) Regonol) VG Tacrine (Cognex) VM Insecticides or pesticides Acephate (Orthene) Dichlorvos (DDVP, Vapona) Formetanate (Carzol) Oxydemeton-methyl (Meta Aldicarb (Temik) Dicrotophos (Bidrin) Fenthion (Baytex, Tiguvon, Entex) systox-R) Azinphos-methyl (Guthion) Diisopropyl fluorophosphate Fonofos (Dyfonate) Parathion (Niran, Phoskil) Bendiocarb (Ficam) (Dyflos) Isofenphos (Oftanol, Amaze) Phorate (Thimet) Bufencarb Dimethoate (Cygon, De-Fend) Malathion (Cythion) Phosalone (Zolonc) Carbaryl (Sevin) Dioxathion (Delnav) Methamidophos (Monitor) Phosmet (Imidan, Prolate) Carbofuran (Furadan) Disulfoton (Di-Syston) Methidathion (Supracide) Phosphamidon (Dimecron) Carbophenothion (Trithion) EPN Methiocarb (Mesurol) Pirimicarb (Pirimor) Chlorfenvinphos (Birlane) Ethiofencarb Methomyl (Lannate, Nudrin) Propoxur (Baygon) Chlorpyrifos (Dursban, Lorsban) Ethion Methyl parathion (Penncap-M) Temephos (Abate) Coumaphos (Co-Ral) Ethoprop (Mocap) Mevinphos (Phosdrin) TEPP Crotoxyphos (Ciodrin, Ciovap) Famphur Monocrotophos Terbufos (Counter) Crufomate (Ruelene) Fenamiphos (Nemacur) Naled (Dibrom) Tetrachlorvinphos (Rabon, Demeton (Systox) Fenitrothion (Sumithion) Oxamyl (Vydate) Gardona) Diazinon (Spectracide) Fensulfothion (Dasanit) Trichlorfon (Dylox, Neguvon) Copyright Material – Provided by Taylor & Francis Special Drug Groups 5 Anesthetic Agents General Anesthetics General anesthetic agents are commonly used in the clinical setting to induce or maintain anesthesia. When used for this purpose, in a monitored clinical setting and in ventilated patients, the risk of death due to overdose is minimal. Some anesthetic agents are associated with other toxic effects, such as malignant hyperthermia, liver toxicities, and prolonged QT, but a discussion of these effects is beyond the scope of this book. However, when such agents are abused outside of the monitored clinical setting, even therapeutic concentrations can be lethal. Table 2.2 summarizes lethal concentrations of these medications, which have been reported in the literature. Ketamine and propofol deserve special mention and are described in more detail below. • Ketamine • In addition to being a widely used anesthetic agent, ketamine has become a drug of abuse known as Jet, Special K, Vitamin K, and Special K lube when combined with ethanol and gamma hydroxybutyric acid (GHB). • As ketamine is also used as a recreational drug, its presence alone may not indicate a lethal intoxication. The following nontoxic concentrations have been reported: Blood Liver Kidney Brain Cardiac Muscle Skeletal Muscle (mg/L) (mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg) 0.5–9 0.8 0.6 4 3.5 1.2 Table 2.2 Lethal Concentrations of General Anesthetic Agents Anesthetic Blood Vitreous Liver Kidney Brain Lung Muscle Agent (mg/L) (mg/L) (mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg) Etomidate 0.4 0.3 Halothane 3.4–720 1.7–880 12–14 104–1560 500 Isoflurane 1.8–48 31–1000 27–53 29–307 9–34 9 (skeletal) Ketamine 1.5–38 4.9–6.6 3.2–3.6 3.2–4.3 2.4 (cardiac) Nitrous oxide 11–2030 47–2200 370–2420 Propofol 0.03–5.5 1.4–27 1.8–5.5 2.9–17 222 (skeletal) Sevoflurane 8–26 87 31–269 13–29 Copyright Material – Provided by Taylor & Francis 6 Handbook of Forensic Toxicology for Medical Examiners • Propofol • With high volume of distribution and lipophilicity, it can be found several days following a surgical procedure at low tissue and blood concentrations and may not indicate an acute intoxication. • Can cause propofol infusion syndrome—characterized by metabolic acidosis, bradyarrhythmias, rhabdomyolysis, hypo- tension, and cardiac failure. • Therapeutic/nontoxic concentrations of propofol have been reported from 0.4 to 6.8 mg/L in blood. Local Anesthetics Local anesthetics usually result in toxicity and death by central nervous sys- tem excitation and seizure activity. They can also be cardiotoxic, resulting in arrhythmias and ventricular fibrillation. Tables 2.3 and 2.4 summarize the pharmacokinetic properties and non- lethal and lethal concentrations of several local anesthetic agents. Table 2.3 Pharmacokinetic Parameters and Toxic and Lethal Concentrations of Local Anesthetic Agents Nontoxic Nontoxic Toxic Lethal Lethal Anesthetic Blood Liver Blood Blood Liver Agent ʎ (h) Vd (L/kg) (mg/L) (mg/kg) (mg/L) (mg/L) (mg/kg) Benzocaine Unknown Unknown 0.05–0.5 1.0–5.2a 3.5a Bupivacaine 1–3 0.4–1 0.2–3.5 0.3–20 3.8 Lidocaine 0.7–5 1–4 0.3–5 0.01–4 8–12 12–44 10–96 Mepivacaine 1.5–2 0.5–4 0.1–5 4–9 16b–50 75 Prilocaine 0.5–2.5 0.7–4 0.9–5 0.3–2.8 13–15 14a–49 Procaine 7–8 min 0.3–1 4–43 18–96 Ropivacaine 2–4 0.5–1 0.4–3 1.5–6 2 4.4 a Children. b Mixed with lidocaine 4.9 mg/L. Table 2.4 Additional Tissue Concentrations for Lidocaine and Mepivacaine Nontoxic Concentrations Lethal Concentrations Cardiac Skeletal Cardiac Skeletal Anesthetic Kidney Brain Muscle Muscle Kidney Brain Muscle Muscle Agent (mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg) (mg/kg) Lidocaine 0.01–15 0.01–5.9 0.8 0.9–2.9 12–204 6.6–135 9–13 20 Mepivacaine 51–59 51–83 51 51 Copyright Material – Provided by Taylor & Francis Special Drug Groups 7 Lidocaine, benzocaine, and prilocaine deserve special mention and are described in additional detail below. • Benzocaine and prilocaine toxicity can result in methemoglobinemia. • Lidocaine is metabolized by CYP 1A2 and 3A4 to the active metab- olite, monoethylglycinexylidide (MEGX) and has been used as an adulterant in illicit drugs. Neuromuscular Blocking Agents Neuromuscular blocking agents block neuromuscular transmission at the neuromuscular junction, resulting in paralysis. These are most often used in anesthesia to assist in intubation. The use of these agents in the clinical setting, while the patient is being artificially ventilated, should not result in death. The presence of these agents outside of a clinical setting, in a non- ventilated patient, can result in death at any concentration. Common neuromuscular blocking agents include: atracurium, cisatra- curium, doxacurium, gallamine, mivacurium, pancuronium, pipecuronium, rapacurium, rocuronium, succinylcholine, tubocurarine, and vecuronium. Succinylcholine deserves an additional note, because it • Can be difficult to find in postmortem cases due to short half-life. • Absorbs onto glassware during storage. • Is rapidly hydrolyzed to succinylmonocholine, choline, and succinic acid, all of which are found endogenously. Copyright Material – Provided by Taylor & Francis 8 Handbook of Forensic Toxicology for Medical Examiners Metals and Metalloids Humans are exposed to metals and elements through the environment, food and water, smoking, and certain occupations or hobbies. Some metals have also been used not only medicinally but also as poisons, including being components of insecticides or pesticides. The concentrations of metals seen in blood and tissues are often extremely variable due to diet, environment, and occupation, making interpretation of postmortem metal concentrations extremely difficult; it is rec- ommended that such interpretation be done with great skepticism and reflection. Metals tend to be eliminated by and accumulate in the kidneys, so renal tissue is often the preferred tissue when testing for an acute overdose. Chronic exposure can often be delineated by testing of the hair and/or fingernails. Tables 2.5 and 2.6 outline reported metal concentrations. Numerous procedures can be utilized to test for metals, including inductively coupled plasma mass spectrophotometry (ICP), atomic absorption spectros- copy (AAS), atomic emission spectrophotometry (AES), and x-ray defraction. Be certain to contact the testing laboratory for any specific requirements. The following metals deserve special consideration: Aluminum • Classic exposure was through dialysis; no longer common. • Blocks incorporation of calcium into bone. • Associated with elevated calcium concentrations. Arsenic • Is a metalloid. Used medicinally for years. • A known carcinogen. • Elemental arsenic (Aso) is not toxic; can be found in shellfish and seafood. +5 +3 • Arsenate (As ), arsenite (As ), and arsine gas (AsH3) are toxic— +5 +3 As < As < AsH3. • Can cause white lines
Load more

Recommended publications
  • Case: 1:18-Cr-00474-JRA; Zheng ECF Filed Indictment
    Case: 1:18-cr-00474-JRA Doc #: 1 Filed: 08/17/18 1 of 83. PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO EASTERN DIVISION UNITED STATES OF AMERICA, ) INDICTMENT Plaintiff, ~ JUDGE PO V. ~ CASE10; 18 CR ) Title 21, Sections 33l(a), FUJINO ZHENG, ) 333(b)(7), 35l(d), 841(a)(l), aka, GORDON JIN, ) (a)(2), (b)(l)(A), (b)(l)(C), (h), aka, MR. JIN, ) 843(c)(2)(A), 846, 848, 853, aka, GORDON ZHENG, ) 952(a), 959(a), 960(a)(l) and (3), aka, JINXINXIN, ) (b)(1 ), (b )(3), 963, and 970, aka, FU JING ZHENG, ) Title 18, Sections 1956(a)(2), (h), aka, DENG GAO, ) and 2, GUANGHUA ZHENG, ) United States Code aka, GUANG HUA ZHENG, ) ) Defendants. ) ) COUNT 1 (Conspiracy to Manufacture, Distribute, and Possess with the Intent to Distribute Controlled Substances and Controlled Substance Analogues Resulting in Death, 21 U.S.C. §§ 841(a)(l), (b)(l)(A), (b)(l)(C), all in violation of 21 U.S.C. § 846) The Grand Jury charges: 1. From on or about January 1, 2008 to the Present, the exact dates unknown to the Grand Jury, in the Northern District of Ohio, Eastern Division, the People's Republic of China, and elsewhere, Defendants FUJINO ZHENG, aka GORDON JIN, aka MR. JIN, aka GORDON ZHENG, aka JINXINXIN, aka FU JING ZHENG, aka DENG GAO; GUANGHUA ZHENG, aka GUANG HUA ZHENG; Guangfu Z.; Guifeng C.; Songyan J.; Longbao Z.; Qinghua Y., aka Jason Yen; Lynn X.; Leroy S.; (individuals whose names are known to the Grand Jury); Global United Biotechnology; Global United Holdings; Global Biotech, Inc.; Global Holdings, Inc.; Top Lab RC; Global RC; Golden Chemicals; Cambridge Chemicals; Wonda Science; OneChem; Case: 1:18-cr-00474-JRA Doc #: 1 Filed: 08/17/18 2 of 83.
    [Show full text]
  • The Real Deal on Synthetic Drugs
    2 presentations (part one) table of contents Community Drug Early Warning System: Recent Findings for Washington, DC 3 Bath Salts and Spice: Facts and Strategies 36 A Forensic Perspective on Synthetic Drug Trends 64 The Real Deal on Synthetic 3 Drugs: Recent Findings for Washington, DC July 17, 2014 Presented by: Eric D. Wish, Ph.D. Erin Artigiani, MA Center for Substance Abuse Research University of Maryland College Park www.cesar.umd.edu [email protected] 4 CESAR is… • Founded in 1990 as an interdisciplinary research center at the University of Maryland, College Park • Conducts policy-relevant research in all areas related to substance abuse • Maintains a clearinghouse of substance abuse information • Publishes the weekly CESAR Fax • Specializes in applied epidemiology 5 6 Source: Center for Substance Abuse Research (CESAR), Community Drug Early Warning System (CDEWS), December 2013. 2014* 13.0 2013 2012 2011 2010 2009 2008 2007 2006 7 2005 2004 2003 2002 2001 2000 District Columbia. forthe of Agency 1999 1998 Services 1997 Pretrial Pretrial June 2014 June 1996 - 1995 1994 1993 1992 1984 1991 1990 1989 1988 1987 1986 1985 1984 SOURCE: Adapted by from the by CESAR from data SOURCE: Adapted 0 Percentage of Washington, DC, Adult DC, of Washington, Percentage 20 10 40 30 60 50 70 Arrestees Testing Positive for Cocaine: Cocaine: for Positive Testing Arrestees Arrestees Testing Positive for Marijuana: for Positive Testing Arrestees 10 20 30 40 50 60 70 Percentage of Washington, DC, Juvenile Juvenile DC, of Washington, Percentage 0 1987 SOURCE: Adapted by from the by CESAR from data SOURCE: Adapted 1988 1989 1990 1991 1992 8 1993 1994 1987 1995 1996 1997 1998 - June 2014 June Pretrial Pretrial 1999 2000 Services Services 2001 2002 Agency District Columbia.
    [Show full text]
  • ENGR. SB NO. 12 Page 1 1 2 3 4 5 6 7 8 9 10 11
    1 ENGROSSED SENATE BILL NO. 12 By: Standridge of the Senate 2 and 3 Kannady of the House 4 5 6 An Act relating to Uniform Controlled Dangerous Substances Act; amending 63 O.S. 2011, Section 2-204, 7 as last amended by Section 1, Chapter 207, O.S.L. 2019 (63 O.S. Supp. 2020, Section 2-204), which 8 relates to Schedule I; modifying inclusions; and providing an effective date. 9 10 11 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA: 12 SECTION 1. AMENDATORY 63 O.S. 2011, Section 2-204, as 13 last amended by Section 1, Chapter 207, O.S.L. 2019 (63 O.S. Supp. 14 2020, Section 2-204), is amended to read as follows: 15 Section 2-204. The controlled substances listed in this section 16 are included in Schedule I and include any material, compound, 17 mixture or preparation that contains any quantity of the following 18 hallucinogenic substances, their salts, isomers and salts of 19 isomers, unless specifically excepted, when the existence of these 20 salts, isomers and salts of isomers is possible within the specific 21 chemical designation. 22 A. Any of the following opiates, including their isomers, 23 esters, ethers, salts, and salts of isomers, esters, and ethers, 24 unless specifically excepted, when the existence of these isomers, ENGR. S. B. NO. 12 Page 1 1 esters, ethers, and salts is possible within the specific chemical 2 designation: 3 1. Acetylmethadol; 4 2. Allylprodine; 5 3. Alphacetylmethadol; 6 4. Alphameprodine; 7 5. Alphamethadol; 8 6.
    [Show full text]
  • 1 Councilmember Charles Allen 2 3 4 5 a BILL
    1 ___________________________ 2 Councilmember Charles Allen 3 4 5 6 A BILL 7 8 _____ 9 10 11 IN THE COUNCIL OF THE DISTRICT OF COLUMBIA 12 13 __________ 14 15 16 To amend, on an emergency basis, due to congressional review, the District of Columbia 17 Uniform Controlled Substances Act of 1981 to add certain classes and substances to the 18 list of Schedule I controlled substances. 19 20 BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this 21 act may be cited as the “Revised Synthetics Abatement and Full Enforcement Drug Control 22 Congressional Review Emergency Amendment Act of 2018”. 23 Sec. 2. The District of Columbia Uniform Controlled Substances Act of 1981, 24 effective August 5, 1981 (D.C. Law 4-29; D.C. Official Code § 48-901.01 et seq.), is amended as 25 follows: 26 (a) Section 102(27) (D.C. Official Code § 48-901.02(27)) is amended as follows: 27 (1) Strike the phrase “as used in section 204(3) and section 206(1)(D)” and insert 28 the phrase “as used in section 204(3), (5), and (6) and section 206(1)(D)” in its place. 29 (2) Strike the phrase “As used in section 204(3)” and insert the phrase “As used in 30 section 204(3), (5), and (6)” in its place. 31 (b) Section 204 (D.C. Official Code § 48-902.04) is amended as follows: 32 (1) Paragraph (3) is amended as follows: 1 33 (A) The lead-in language is amended by striking the phrase “(for purposes 34 of this paragraph only, the term “isomer” includes the optical, position, and geometric isomers):” 35 and inserting a colon in its place.
    [Show full text]
  • New Psychoactive Substances (NPS)
    New Psychoactive Substances (NPS) LGC Quality Reference ISO 9001 ISO/IEC 17025 ISO Guide 34 materials GMP/GLP ISO 13485 2019 ISO/IEC 17043 Science for a safer world LGC offers the most extensive and up-to-date range of New LGC is a global leader in Psychoactive Substances (NPS) measurement standards, reference materials. reference materials, laboratory services and proficiency testing. With 2,600 professionals working When you make a decision using The challenge The LGC response We are the UK’s in 21 countries, our analytical our resources, you can be sure it’s designated National measurement and quality control based on precise, robust data. And New Psychoactive Substances In response to the ever-expanding LGC Standards provides the widest Measurement services are second-to-none. together, we’re creating fairer, safer, (NPS) continue to be identified, range of NPS being developed, LGC range of reference materials Institute for chemical more confident societies worldwide. and it appears that moves by the has produced a comprehensive available from any single supplier. and bioanalytical As a global leader, we provide the United Nations and by individual range of reference materials that We work closely with leading widest range of reference materials lgcstandards.com countries to control lists of meet the rapidly changing demands manufacturers to provide improved measurement. available from any single supplier. named NPS may be encouraging of the NPS landscape. Many of access to reference materials, the development of yet further these products are produced under with an increasingly large range variants to avoid these controls. the rigorous quality assurance of parameters, for laboratories standards set out in ISO Guide 34.
    [Show full text]
  • Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, Effective January 20, 2021)
    1 Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, effective January 20, 2021) Schedule I (a) Schedule I shall consist of the drugs and other substances, by whatever official name, common or usual name, or brand name designated, listed in this section. Each drug or substance has been assigned the DEA Controlled Substances Code Number set forth opposite it. (b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation (for purposes of 3-methylthiofentanyl only, the term isomer includes the optical and geometric isomers): (1) Acetyl-alpha-methylfentanyl (N-[1-[1-methyl-2-phenethyl]-4-piperidinyl]- N-phenylacetamide -------------------------------------------------------------------- 9815 (Federal Control Nov. 29, 1985; State Dec. 29, 1985) (2) Acetylmethadol ------------------------------------------------------------------------- 9601 (3) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl] benzamide -------------------------------------------------------------------------------- 9551 Federal Control May 16, 2016; State June 15, 2016 (4) Allylprodine ----------------------------------------------------------------------------- 9602 (5) Alphacetylmethadol --------------------------------------------------------------------- 9603 (6) Alphameprodine
    [Show full text]
  • Testing for 'Spice' and Everything Nice
    3/17/2016 Testing for ‘Spice’ and Everything Nice Andrew Stolbach, MD March 17, 2016 Objectives List different classes of synthetic cannabinoids Describe commercially available testing modalities for SC drugs Discuss clinical and forensic uses of SC testing Discuss limitations of clinical and forensic SC testing Recap JWH-018, the naphthoylindole synthetic cannabinoid sweeps the world in 2008 1 3/17/2016 Recap United States Drug Laws were not adequate to address the epidemic SC Drugs do not meet strict definition of controlled substance analogs SC drugs were eventually scheduled on emergency, individual basis Cyclohexylphenol SC Structure Core Link Ring Tail Source : EMDCCA 2 3/17/2016 Naphthoylindole Naphthylmethylindole Phenylacetylindole 3 3/17/2016 Tetramethylcyclopropylindole Adamantylcarboximideindole Adamantylcarboximideindazole 4 3/17/2016 Quinolinoylcarboxylateindole Naming of SC Compounds JWH Compounds named after J.W. Huffman Naming of SC Initials of Scientist JWH AM- Compounds Compounds named after named after J.W. Alexander Huffman Makriyannis JW Huffman Alexander Makriyannis 5 3/17/2016 Naming of SC Space Shuttle Mission STS-135 Naming of SC Japanese Girl Band AKB-48 Naming of SC Contraction of IUPAC Name N-(1-adamantyl)-1-pentyl-1H- indazole-3-carboxamide = APINACA 6 3/17/2016 Non-comprehensive list of SC 5C-MN-24 (5-C-NNEI) ADB-FUBINACA FU-AEB JWH-249 PX-2 (5F-APP-PINACA) FUB-144 (FUB-UR-144) 5F-AB-PINACA ADB-PINACA JWH-250 PX-3 (APP-CHMINACA) FUB-AMB (AMB-FUBINACA) JWH-251 5F-ADB (5F-MDMB-PINACA) ADBICA (ADB-PICA) QUCHIC
    [Show full text]
  • Testing for 'Spice' and Everything Nice
    Testing for ‘Spice’ and Everything Nice Andrew Stolbach, MD March 17, 2016 Objectives List different classes of synthetic cannabinoids Describe commercially available testing modalities for SC drugs Discuss clinical and forensic uses of SC testing Discuss limitations of clinical and forensic SC testing Recap JWH-018, the naphthoylindole synthetic cannabinoid sweeps the world in 2008 Recap United States Drug Laws were not adequate to address the epidemic SC Drugs do not meet strict definition of controlled substance analogs SC drugs were eventually scheduled on emergency, individual basis Cyclohexylphenol SC Structure Core Link Ring Tail Source : EMDCCA Naphthoylindole Naphthylmethylindole Phenylacetylindole Tetramethylcyclopropylindole Adamantylcarboximideindole Adamantylcarboximideindazole Quinolinoylcarboxylateindole Naming of SC Compounds JWH Compounds named after J.W. Huffman Naming of SC Initials of Scientist JWH AM- Compounds Compounds named after named after J.W. Alexander Huffman Makriyannis JW Huffman Alexander Makriyannis Naming of SC Space Shuttle Mission STS-135 Naming of SC Japanese Girl Band AKB-48 Naming of SC Contraction of IUPAC Name N-(1-adamantyl)-1-pentyl-1H- indazole-3-carboxamide = APINACA Non-comprehensive list of SC 5C-MN-24 (5-C-NNEI) ADB-FUBINACA FU-AEB JWH-249 PX-2 (5F-APP-PINACA) FUB-144 (FUB-UR-144) 5F-AB-PINACA ADB-PINACA JWH-250 PX-3 (APP-CHMINACA) FUB-AMB (AMB-FUBINACA) JWH-251 5F-ADB (5F-MDMB-PINACA) ADBICA (ADB-PICA) QUCHIC (BB-22) AM-1220 FUB-APINACA JWH-302 5F-AEB QUPIC (PB-22) AM-1221 FUB-PB-22 JWH-320
    [Show full text]
  • Dangerous Drugs Ordinance [New Version], 5733-1973 ______This Is an Unofficial Translation for Information Purposes Only
    עמוד 1 מתוך 64 Dangerous Drugs Ordinance [New Version], 5733-1973 _____________________________________________________________________ This is an unofficial translation for information purposes only DANGEROUS DRUGS ORDINANCE [NEW VERSION], 5733 - 1973 Penalties and criminal law - offences - dangerous drugs Courts and legal procedures - criminal procedure - dangerous drugs Health - drugs - dangerous drugs Table of Contents Chapter 1: Interpretation Go 4 Section 1 Definitions Go 1 Chapter 2: Permits Go 5 Section 2 Details of Import Permit Go 1 Section 3 Details of Export Permit Go 1 Section 4 Details of Diversion Permit Go 1 Section 5 The Competent Authority in Israel Go 1 Chapter3: Offences Go 5 Section 6 Manufacture, Preparation and Procurement Go 1 Section 7 Possession and Use Go 1 Section 8 Meaning of Possession Go 1 Section 9 Premises Go 1 Section 10 Tools Go 1 Section 10A Prohibited Devices Go 1 Section 11 Permitted Possession Go 1 Section 12 Permitted Use Go 1 Section 13 Export, Import, Trade and Supply Go 1 עמוד 2 מתוך 64 Section 14 Agency Go 1 Section 15 Transportation of Dangerous Drugs in Transit Go 1 Section 16 Diversion Go 1 Section 17 Moving a Drug in Transit Go 1 Section 18 Damage to a Drug in Transit Go 1 Section 19 Exception Go 1 Section 19A Penalty Go 1 Section 20 Inspection of Dangerous Drugs in Transit Go 1 Section 21 Drug Offences Involving the Corruption of Minors Go 1 Section 22 Exception Go 1 Section 23 Ways of Committing the Offence Go 1 Section 24 Presumptions Go 1 Section 25 Mandatory Imprisonment Go 1 Chapter
    [Show full text]
  • Armenia Criminal Code As of 23 May 2018
    Strasbourg, 12 March 2021 CDL-REF(2021)022 Opinion No. 1026 / 2021 Engl. only EUROPEAN COMMISSION FOR DEMOCRACY THROUGH LAW (VENICE COMMISSION) ARMENIA CRIMINAL CODE AS OF 23 MAY 2018 (*) (*) Translation provided by the Armenian authorities This document will not be distributed at the meeting. Please bring this copy. www.venice.coe.int CDL-REF(2021)022 - 2 - CRIMINAL CODE OF THE REPUBLIC OF ARMENIA (Adopted on 18 April 2003) GENERAL PART SECTION 1 CRIMINAL STATUTE CHAPTER 1 TASKS AND PRINCIPLES OF CRIMINAL LEGISLATION Article 1. Criminal legislation of the Republic of Armenia 1. The criminal legislation of the Republic of Armenia consists of this Code. New laws that envisage criminal liability shall be included in the Criminal Code of the Republic of Armenia. 2. The Criminal Code of the Republic of Armenia is based on the Constitution of the Republic of Armenia and on principles and norms of international law. Article 2. Tasks of the Criminal Code of the Republic of Armenia 1. Tasks of the Criminal Code of the Republic of Armenia shall be as follows: to protect human and citizens’ rights and freedoms from criminal encroachments, rights of legal entities, property, environment, public order and security, constitutional order, peace and safety of humanity, as well as to prevent crimes. 2. For the purpose of implementing these tasks, the Criminal Code of the Republic of Armenia stipulates the ground for criminal liability and the principles of criminal legislation, determines what acts dangerous to the public are deemed to be crimes and defines the types of punishment and other criminal-law enforcement measures for commission thereof.
    [Show full text]
  • D.C. Act 22-550
    ENROLLED ORIGINAL AN ACT D.C. ACT 22-550 IN TFIE COUNCIL OF"IIIE DISTRICT OF COLUMBIA DEGEMBER 26,2018 To amcnd, on an emergency basis, due to congressional review, the District of Columbia ljniform Controlled Substances Act of 198 I to add certain classes and substances to the list of Schedule I controlled substances. BE IT ENACTED BY THE COTJNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Revised Synthetics Abatement and F-ull Enforcement Drug Control Congressional Review Emergency Amendment Act of 20 I 8". Sec. 2. The District of Columbia Uniform Controlled Substances Act of 1981, effective August 5, 1981 (D.C. Law 4-29: D.C. Official Code $ 48-901.01 et seq.), is amended as follows: (a) Section 102(27) (D.C. Official Code $ 48-901.02(27) is amended as fo[[ows: ( I ) Strike the phrase "as used in section 204(l) and section 206( IXD)" and insert the phrase "as used in section 204(3), (5), and (6) and section 206( I )(D)" in its place. (2) Strike the phrase "As used in section 204(3)" and insert the phrase "As used in section 204(3). (5), and (6)" in its place. (b) Section 204 (D.C. Official Code $ 48-902.04) is amended as follows: (1) Paragraph (3) is amended as lollows: (A) The lead-in language is amended by striking the phrase "(for purposes of this paragraph only. the term "isomer" includes the optical, position, and geometric isomers):" and insening a colon in its place. (B) New subparagraphs (G-i) through (G-xii) are added to read as follows: "(G-i) 251-NBOMe (also known as 4-iodo-2,5-dimethoxy-N-[(2- methoxyphenyl)methyl]-benzeneethanamine);
    [Show full text]
  • Substance Abuse in the Workplaces of Our Bodies and Mind
    “Turn on, Tune in, Drop out “ Substance Abuse in the Workplaces of our bodies and mind.. Warren Silverman MD Brief History of Drug abuse – Mary Jane 1629 – Marijuana introduced to the Puritan colonies of New England 1765 – George Washington was cultivating Marijuana for a sore tooth 1800’s Tincture of Cannabis is available from pharmacies, unpopular due to variations in potency and dosage, but recreational use continues with Hashish clubs in most cities by 1885 By the 20th century, marijuana use was associated with racial groups and drug abusers and lost popularity The foreign origin of marijuana lead to propaganda against its use (as we have just seen), by 1930’s marijuana was considered wicked In the 1960’s, drug use was considered a demonstration of anti-establishment leanings and became popular Marijuana has remained a constant presence in our society with gradual legislation to decriminalize and legitimize its use Brief History of Drug Abuse - Opiates In colonial America, Opiate medications were common in London and imported to the colonies – used to treat pain from diarrhea, colds, fever, tooth aches, cholera, rheumatism, pelvic disorders, athlete’s foot and baldness 1784 Dr. William Buchan’s book tells people how to make their own tincture of Opium (paregoric) to keep around the house 1804 catalogue listed 90 brands of elixir, by 1905 it was more than 28,000 1803 Morphine developed (Morpheus – god of dreams) Hypodermic needle invented and by the civil war Morphine was widely used as injectable 1898 Heroin developed
    [Show full text]